Thu, Mar 5, 2015, 7:47 AM EST - U.S. Markets open in 1 hr 43 mins


% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • nanospeak nanospeak Jun 18, 2014 9:22 PM Flag

    Give me an example of corrupt behavior on the part of the FDA

    Is the FDA corrupt? Please explain.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Generally speaking, no.

    • pepperoniandmushrooms2003 pepperoniandmushrooms2003 Jun 18, 2014 10:48 PM Flag

      farmaggedon. its a movie.
      FDA seized and closed down private small dairy farmers across the country who were selling "whole milk, raw milk"
      children who drank the milk were cured of their allergies and asthma, all sorts of great healthy stuff was taking place when people drank raw milk. FDA closed these farms down. many farmers battled them in court, in court the FDA said and I quote "Humans do not possess the right to good health" This was their argument in a court of law !

      The movie is very interesting, they want us to be sick, they don't want us to live longer lives and eat healthy natural foods.

      They wont allow many herbs to be sold, you cant sell herbs and claim health benefits, you can only claim that you might feel better. But you cant claim any direct health benefits selling herbal remedies or the FDA will close you down and prosecute you.

      The FDA allows all sorts of poisons into our foods, but don't allow good clean real foods to be sold.

      There is a huge push back now against the FDA and pesticides and no organic foods.

      It is very hard to find raw un pasturized milk because the FDA does not want people to be cured of their ailments when drinking raw milk.

    • There are two parts to this possible scandal about Afrezza, one involving Cheng Yi Liang, a chemist at the FDA's Center for Disease Evaluation and Research and the second and most compelling has to do with Martin Shkreli, who is chief investment officer for New York-based hedge fund MSMB Capital Management LLC.

      Cheng Yi Liang has been charged by the Securities and Exchange Commission in United States District Court for making 27 trades in 19 companies in advance of announcements concerning the FDA's decision on these drug applications. Liang typically began building his stock positions 2-3 weeks prior to PDUFA date using non-public details and results of FDA reviews. One thing is certain, by virtue of his position within the CDER, Liang was privy to confidential FDA information including impending decisions regarding approvals. Liang had computer access to nonpublic FDA information of the review process for each drug.

      Mannkind Corporation was one of the companies in which Liang bought stock using this non‑public information. He used that information when he purchased 18,000 shares of MannKind stock before the PDUFA date knowing the FDA was planning on approving Afrezza. The PDUFA date for Afrezza was Dec. 29, 2010, but at the last moment, MannKind received an action date delay of 3-4 weeks. With that being said, Liang, with his advance details of the FDA review, knew MannKind's Afrezza was on track for approval. This is consistent with MannKind's comments that the dialogue with the agency had been positive, and that there was no reason to believe that they would not get approval.

    • Seriously. The FDA favors Big Pharma. So smaller companies get hosed.

5.94-0.22(-3.57%)Mar 4 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.